The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →For the second quarter of 2026, Johnson & Johnson reported $25.310 billion in sales, compared with Bristol Myers Squibb’s $12.973 billion in total revenues. The figures are a useful snapshot of reported top-line scale, but the companies use different labels for their totals.
Q2 2026 quarterly results at a glance
| Company | Q2 2026 reported amount | Q2 2025 comparison | Company’s label | Reported year-over-year growth |
|---|---|---|---|---|
| Bristol Myers Squibb (BMS, NYSE: BMY) | $12.973 billion | $12.269 billion | Total revenues | 6% |
| Johnson & Johnson (J&J, NYSE: JNJ) | $25.310 billion | $23.743 billion | Reported sales | 6.6% |
BMS’s figures are from its Form 10-Q for the quarter ended June 30, 2026, filed July 30. J&J published its Q2 results on July 15, 2026. These are company-reported, unaudited interim-period results; BMS notes that amounts may not sum due to rounding. BMS Form 10-Q · J&J Q2 2026 results
How to read the comparison
J&J’s reported sales were about 1.95 times BMS’s total revenues in this quarter, based on the reported dollar amounts. That describes scale for this period; it does not mean the companies’ accounting categories are identical. BMS’s consolidated statement includes net product sales and alliance and other revenues, while J&J reports sales across its Innovative Medicine and MedTech segments. Use the issuer-specific labels when presenting or citing the totals. BMS Form 10-Q · J&J Q2 2026 results
Reported growth is not the same as adjusted growth
The 6% for BMS and 6.6% for J&J are their reported year-over-year growth figures. Currency-adjusted measures answer a different question and should not be substituted for reported growth or shown as revenue amounts.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
#1 Best Overall
- BMS: reported revenue growth was 6%; growth excluding foreign exchange was 5%.
- J&J: reported sales growth was 6.6%; operational growth excluding translational currency was 5.6%; adjusted operational growth excluding the net impact of acquisitions and divestitures and translational currency was 5.7%.
The companies’ release definitions differ, so these adjusted rates are not directly interchangeable. BMS Q2 2026 earnings release · J&J Q2 2026 results
How to make a fair bar chart
- Title the chart “Q2 2026 reported top line” and identify the period clearly.
- Plot two bars on the same zero-based axis in U.S. dollars, billions: BMS at $12.973 billion and J&J at $25.310 billion.
- Label the bars with each company’s own measure name: “Total revenues” for BMS and “Reported sales” for J&J.
- Put the Q2 2025 comparisons and reported growth rates in a separate annotation or accompanying text. Do not encode operational or adjusted operational growth as if it were a dollar amount.
This layout preserves a readable scale comparison while making clear that the issuer labels and revenue composition are not identical.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Why the period matters
This is a comparison of the latest quarterly results available as of October 3, 2026, not a multi-quarter trend. The next earnings releases can change which quarter is the latest; confirm the reporting period before reusing the figures. J&J’s investor site lists its quarterly releases and related materials on its quarterly results page.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
